Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedNew study sites were added, including Taipei Veterans General Hospital (Site 1652), Taichung Veterans General Hospital (Site 1653), and China Medical University Hospital-Department of Urology (Site 1654), among others. The total number of locations is now listed as 209.SummaryDifference0.8%

- Check16 days agoChange DetectedRevision tag changed from v3.5.2 to v3.5.3. This update represents a revision history increment without modifying the information shown on the page.SummaryDifference0.0%

- Check23 days agoChange DetectedLocation labels updated from Vienna to State of Vienna, with the address now shown as Vienna, State of Vienna, Austria, 1090 (replacing Vienna, Vienna, Austria, 1090); revision bumped from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check45 days agoChange DetectedAbbotsford, British Columbia, Canada, V2T 1X8 entry was reformatted to Abbotsford British Columbia, British Columbia, Canada, V2T 1X8 in the location list.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the Study Details content or its functionality.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.